- Home
- IMVT vs EQX Comparison
IMVT vs EQX Comparison
Compare IMVT & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- EQX
- Stock Information
- Founded
- IMVT 2018
- EQX 2007
- Country
- IMVT United States
- EQX Canada
- Employees
- IMVT N/A
- EQX N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- EQX Precious Metals
- Sector
- IMVT Health Care
- EQX Basic Materials
- Exchange
- IMVT Nasdaq
- EQX Nasdaq
- Market Cap
- IMVT 2.8B
- EQX 3.2B
- IPO Year
- IMVT N/A
- EQX N/A
- Fundamental
- Price
- IMVT $16.95
- EQX $5.81
- Analyst Decision
- IMVT Buy
- EQX
- Analyst Count
- IMVT 10
- EQX 0
- Target Price
- IMVT $40.14
- EQX N/A
- AVG Volume (30 Days)
- IMVT 1.4M
- EQX 18.2M
- Earning Date
- IMVT 08-05-2025
- EQX 08-06-2025
- Dividend Yield
- IMVT N/A
- EQX N/A
- EPS Growth
- IMVT N/A
- EQX N/A
- EPS
- IMVT N/A
- EQX 0.64
- Revenue
- IMVT N/A
- EQX $1,696,526,000.00
- Revenue This Year
- IMVT N/A
- EQX $40.61
- Revenue Next Year
- IMVT N/A
- EQX $14.56
- P/E Ratio
- IMVT N/A
- EQX $14.36
- Revenue Growth
- IMVT N/A
- EQX 54.88
- 52 Week Low
- IMVT $12.72
- EQX $4.48
- 52 Week High
- IMVT $34.47
- EQX $7.45
- Technical
- Relative Strength Index (RSI)
- IMVT 60.86
- EQX 37.70
- Support Level
- IMVT $15.80
- EQX $5.66
- Resistance Level
- IMVT $17.06
- EQX $5.95
- Average True Range (ATR)
- IMVT 0.68
- EQX 0.20
- MACD
- IMVT 0.07
- EQX -0.05
- Stochastic Oscillator
- IMVT 86.70
- EQX 16.89
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.